Neonatal & Fetal (Labor & Delivery) Care Equipment Market Expected to Raise Moderately over 2028

Hurry Up..Year-End Mega Sale Is Live Now....!

Market Overview
The Neonatal & Fetal (Labor & Delivery) Care Equipment Market is projected to grow at a CAGR of approximately 6.5% through 2028, driven by rising global awareness of maternal and neonatal health, increasing rates of premature births, and continuous technological advancements in labor, delivery, and newborn care solutions. As the number of low birth-weight infants grows and healthcare systems modernize their labor and neonatal care practices, the demand for innovative equipment to support the health of newborns continues to intensify. Neonatal and fetal care equipment includes a broad spectrum of specialized devices such as incubators, fetal monitors, radiant warmers, and advanced neonatal ventilators. These tools provide essential support across labor, delivery, and the immediate post-birth period, ensuring the stability, safety, and health of both mothers and newborns.

Growing Adoption of Neonatal & Fetal Monitoring Equipment to Reduce Stillbirths, Pre-term Births & Birth Defects
Increasing adoption of neonatal and fetal monitoring systems is one of the most influential factors propelling market growth, particularly as global health agencies emphasize early detection and timely interventions.
In 2021 alone, an estimated 1.9 million stillbirths were recorded worldwide, meaning that one out of every 72 births resulted in a stillborn infant. This represents a staggering occurrence of one stillbirth every 17 seconds. Additionally, congenital disorders contribute to approximately 240,000 newborn deaths within the first 28 days of life each year, with 3%–6% of infants globally being born with serious birth defects. Preterm birth also remains a critical challenge, with nearly 15 million premature babies born annually—more than one in every ten births. Complications associated with preterm deliveries continue to be the leading cause of mortality among children under five years old.
Against this backdrop, advanced fetal and neonatal monitoring equipment plays an essential role in mitigating complications, preventing adverse outcomes, and enhancing clinical decision-making during pregnancy and labor.

Fetal monitoring is widely recognized as one of the most effective approaches for detecting fetal distress, irregular heart rhythms, and abnormal uterine activity. Continuous monitoring through electronic fetal monitors offers real-time insights into fetal well-being, enabling early clinical interventions that reduce the risk of stillbirths and preterm delivery.
AI-based assessment tools are also transforming fetal monitoring by offering more accurate estimations of gestational age and fetal development. These AI-driven solutions help minimize the number of elective early inductions and optimize the timing of maternal and neonatal care.
Early detection of birth defects has become a major focus for clinicians and policymakers, and modern imaging technologies play a vital role in this effort. High-resolution ultrasound systems and fetal MRIs allow clinicians to detect abnormalities at earlier stages, improving counseling, planning, and potential interventions. Diagnostic tests such as amniocentesis remain important tools for confirming genetic conditions and structural anomalies between 15 and 20 weeks of pregnancy.

Rising Demand for NICU Equipment Accelerates Market Expansion
The need for advanced neonatal and fetal care equipment is especially prominent in Neonatal Intensive Care Units (NICUs), which manage high-risk and critically ill newborns. The neonatal period—defined as the first 28 days of life—is associated with the highest risk of mortality, making NICUs essential to safeguarding infant survival in complex cases.
Technological advancements within NICUs have significantly improved clinical outcomes for premature and low birth-weight infants. Cutting-edge tools such as respiratory function monitors, AI-enabled diagnostic systems, video laryngoscopy, and automated ventilation technologies are becoming standard components of modern NICU infrastructure.
Healthcare systems around the world are prioritizing NICU modernization to accommodate growing patient loads and improve survival rates.
Recent industry developments further highlight the momentum:
In June 2023, Dräger introduced the FDA-cleared Babyroo TN300, a next-generation open warmer designed to support lung protection and maintain temperature stability from birth through discharge.
In September 2022, InnAccel Technologies and C-CAMP collaborated with the SAMRIDH Healthcare Blended Finance Facility to expand access to indigenous respiratory support solutions in Assam, India, aiming to reduce neonatal mortality associated with respiratory distress syndrome.

Key Market Challenges
Despite strong market momentum, several limitations hinder the widespread adoption of neonatal and fetal care equipment.
High capital and operational costs remain one of the primary obstacles, particularly in low- to middle-income countries. Many regions lack adequately equipped NICUs, creating disparities in neonatal outcomes. Regulatory hurdles also pose challenges, as medical devices must meet stringent safety and quality standards before receiving market approval.
A shortage of skilled healthcare professionals trained to operate advanced neonatal equipment further restricts adoption. Inadequate sterilization standards and the risk of hospital-acquired infections present persistent concerns, especially in resource-constrained settings.

Regional Insights
North America currently dominates the Neonatal & Fetal (Labor & Delivery) Care Equipment Market due to high rates of premature births, increasing prevalence of neonatal abstinence syndrome, and widespread availability of technologically advanced NICUs. Lifestyle factors such as obesity, smoking, diabetes, and poor maternal nutrition in the region further elevate demand for specialized equipment.
The Asia-Pacific region is projected to exhibit the fastest growth due to rising awareness of neonatal care, high birth rates, substantial populations of preterm and low birth-weight infants, and increasing cases of hospital-acquired neonatal infections. As healthcare infrastructure modernizes across countries such as India and China, demand for advanced fetal and neonatal care devices is expected to grow significantly.

Competitive Landscape
• Atom Medical Corporation
• Becton Dickinson
• Cardinal Health
• Covidien
• Dragerwerk AG & Co. Kgaa
• Fisher & Paykel Healthcare Limited
• GE Healthcare
• Inspiration Healthcare Group Plc
• Koninklijke Philips N.V.
• Masimo
• Medtronic
• Natus Medical Incorporated
• Phoenix Medical Systems
• Others

Strategic Developments by Industry Players
Companies operating in this market are actively pursuing both organic and inorganic growth strategies to strengthen their position. These include product launches, acquisitions, technological collaborations, and strategic partnerships.
In November 2023, Royal Philips secured its second round of funding from the Bill & Melinda Gates Foundation to accelerate AI algorithm adoption for the Lumify Handheld Ultrasound platform, aimed at expanding global maternal health access.
In July 2023, Dräger received FDA 510(k) clearance for its Evita V600, V800, and Babylog VN800 ventilators, expanding its respiratory care offerings across adults, children, and premature infants.
In February 2022, Philips enhanced its Lumify handheld ultrasound system with pulse wave Doppler to improve early gestational assessment and support evaluation of high-risk pregnancies.
The Neonatal & Fetal (Labor & Delivery) Care Equipment Market is set to continue evolving rapidly as technological innovation, rising awareness, and improving healthcare infrastructure collectively shape the future of maternal and neonatal care worldwide.

Key Request a free sample copy or view report summary: https://meditechinsights.com/neonatal-and-fetal-care-equipment-market/request-sample/

About Medi-Tech Insights

Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services in the areas of market assessments, due diligence, competitive intelligence, market sizing and forecasting, pricing analysis & go-to-market strategy. Our methodology includes rigorous secondary research combined with deep-dive interviews with industry-leading CXO, VPs, and key demand/supply side decision-makers.